Episode

SOTS 2nd Hour: Iran Tensions Rise, Chip Stocks Gain - Plus: On Semi CEO, FDA Commissioner Commentary 5/5/26

Podcast
Squawk on the Street
Published
May 5, 2026
Duration seconds
2632
Processing state
not_requested
Canonical source
https://www.cnbc.com
Audio
https://dts.podtrac.com/redirect.mp3/cnbc.simplecastaudio.com/772daf2b-4aa5-445b-9969-6ecd181231b1/episodes/14a61cce-8d8b-4a34-9245-f90d8115e449/audio/128/default.mp3?aid=rss_feed&awCollectionId=772daf2b-4aa5-445b-9969-6ecd181231b1&awEpisodeId=14a61cce-8d8b-4a34-9245-f90d8115e449&feed=GcylmXl7
JSON
/v1/public/podcasts/squawk-on-the-street-731896/episodes/sots-2nd-hour-iran-tensions-rise-chip-stocks-gain-plus-on-semi-ceo-fda-commissioner-commentary-5-5-26
Markdown
/podcast/squawk-on-the-street-731896/sots-2nd-hour-iran-tensions-rise-chip-stocks-gain-plus-on-semi-ceo-fda-commissioner-commentary-5-5-26.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/squawk-on-the-street-731896/episodes/sots-2nd-hour-iran-tensions-rise-chip-stocks-gain-plus-on-semi-ceo-fda-commissioner-commentary-5-5-26/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/squawk-on-the-street-731896/sots-2nd-hour-iran-tensions-rise-chip-stocks-gain-plus-on-semi-ceo-fda-commissioner-commentary-5-5-26.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Escalating tensions in the Strait of Hormuz moving yields and markets... Carl Quintanilla, David Faber, and Sara Eisen kicked off the hour with a contrarian take from investors at the Milken Global Conference - before the team got the latest out from Washington and more on how to navigate the tech trade with one of the street's best, following new numbers from Palantir. Plus: chip stocks in focus after a few key results and a report Apple's contemplating new suppliers... Hear the CEO of On Semi breakdown the demand picture, along with more on some huge moves in the options market. Elsewhere this hour: a deep-dive with the current Commissioner of the FDA - as he pushes back on growing criticism tied to drug approvals. Squawk on the Street Disclaimer